23andMe discontinuing health-related genetic testing

Personal genomics company 23andMe Inc. (Mountain View, Calif.) said it will discontinue consumer access to its health-related genetic testing. Late last month, FDA ordered the company to immediately discontinue marketing its Personal Genome Service (PGS) "for medical device uses" for which the product does not have FDA clearance or approval. 23andMe said it will continue to provide ancestry-related information and raw genetic data without interpretation, but only customers who purchased PGS prior to Nov. 22, the date of the FDA warning letter, will receive or have access to health-related results (see BioCentury Extra, Nov. 25). ...